One of Theranos' blood-testing rivals nabbed a deal with Safeway
Theranos, the Silicon Valley-based startup known for its blood tests that only use a finger-prick's worth of blood, came under fire in October after the Journal raised questions about the accuracy of the company's test results.
Theranos has denied that there's a problem with the tests, but a deal between Theranos and Safeway to put testing clinics in more than 800 supermarkets reportedly fizzled out following the initial report. Theranos has also denied the existence of the Theranos-Safeway deal.
As part of the new deal, which was announced by Sonora Quest last week, Safeway will be opening Sonora Quest Laboratories testing centers in some Arizona stores. One is is already open in Scottsdale. Safeway confirmed the new centers in Scottsdale and Phoenix to the Arizona Republic, but wouldn't discuss details of the deal. The value of the deal was not disclosed.
A Safeway representative told Business Insider that the company would not comment beyond Sonora Quest's news release, noting only that the Theranos and Sonora Quest partnerships are two separate deals.
We've reached out to Sonora Quest and Theranos for comment as well and will update if we hear back.
Sonora Quest is a joint venture made by Banner Health and Quest Diagnostics - one of Theranos' main competitors. The company offers doctor-ordered blood tests and more recently started a limited number of direct-to-consumer blood tests, the Arizona Republic reports. Sonora Quest uses traditional blood testing equipment to run its tests.
Sonora Quest will only provide certain tests directly to consumers, such as lipid panel screening and complete blood counts, Sonora Quest's medical director Robert Stern told the Arizona Republic. More specialized tests will be available only when a physician is involved.
- With the metaverse, NFTs and DeFi on the rise, Ethereum miners rake in $2 billion in revenue — a jump of 11% over October
- Gen Bipin Rawat, his wife, and 11 others killed in chopper crash near Coonoor in Tamil Nadu
- RBI keeps lending rates intact, remains accommodative
- India remains to be ranked as the fourth most powerful country as per Asia Power Index 2021
- Although Shriram Properties has solid future prospects, Omicron may mess things in the near term